A troubled vaccine manufacturer, Emergent BioSolutions, announces a shake-up while projecting record revenues.

By BY SHERYL GAY STOLBERG AND CHRIS HAMBY from NYT World https://ift.tt/3nxovoJ
via theusahealthnews